AMA: FDA action on OTC naloxone will save people from overdoses

| 1 Min Read

Statement attributable to:
Patrice A. Harris, MD, MA
President-elect, chair of the AMA Opioid Task Force
American Medical Association

“The AMA applauds the FDA and Commissioner Gottlieb for today’s action to provide labeling that would allow for over-the-counter availability of naloxone, a move that will save people from opioid-related overdose. Naloxone has saved tens of thousands of lives, and the AMA continues to strongly urge physicians to co-prescribe naloxone to patients at risk of opioid-related overdose.

Full press statement available when you sign in

Sign in to the AMA website to get the full version of this press statement. 

AMA membership has its advantages

  • Be a part of the nation's largest physician organization
  • Play a role in shaping the future of health care
  • Enjoy exclusive perks and savings

Not a member? Become a member now.

 

FEATURED STORIES

Smiling woman sits on couch while typing on laptop

Medicare telehealth coverage renewed for two years

| 5 Min Read
Hand stacking blocks with health care icons

3.1% bonus revived for physicians participating in Medicare APMs

| 5 Min Read
Smiling caregiver embraces older smiling patient

Lawmakers extend CMS hospital-at-home waiver for five years

| 4 Min Read
Hand holds smartphone

AMA expert says what to do—and not do—when measuring doctor burnout

| 12 Min Read